42, 43 These findings suggested that CHST11 may promote Tregs activation and differentiation through the PD‐1/PD‐1 pathway, thereby regulating the immunosuppressive TME and promoting HCC progression. This evidence concerns the gene CHST11 and hepatocellular carcinoma.